Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03373604 · ClinicalTrials.gov registry record · Phase 2

Imaging Tau in Alzheimer's Disease and Normal Aging

A Phase 2 study, sponsored by Patrick Lao.

Completed
Registry status
Phase 2
Development phase
71
Enrollment target

NCT03373604: Completed Phase 2 study, sponsored by Patrick Lao.

NCT03373604 is a Phase 2 study that has completed, run by Patrick Lao. The registered enrollment target is 71 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03373604, a Phase 2 study, has completed, sponsored by Patrick Lao.

COMPLETED
Registry status
Phase 2
Development phase
71 participants
Enrollment target

Study Summary

This study is being done to learn about tau tangles in Alzheimer's disease. A type of positron emission tomography (PET) scan is used to measure the abnormal accumulation of protein called tau in the brain. These are thought to be involved in Alzheimer's disease. The investigators will also perform brain MRI and to tests to measure the participant's memory and thinking.

Primary Outcome

Standardized uptake value ratio (SUVr)

Interventions

  • DRUG 18F-MK-6240
  • PROCEDURE Lumbar Puncture (optional)

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2017-12-11
Est. Completion 2022-05-11
Phase Phase 2
Patrick Lao

3 total trials

What the finished NCT03373604 record still lists

NCT03373604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).

The record links to 0 conditions, and to 2 interventions - of which 18F-MK-6240 is the first listed.

NCT03373604 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03373604 about?

NCT03373604 is a clinical study titled "Imaging Tau in Alzheimer's Disease and Normal Aging". This study is being done to learn about tau tangles in Alzheimer's disease. A type of positron emission tomography (PET) scan is used to measure the abnormal accumulation of protein called tau in the brain. These are thought to be involved in Alzheimer's disease. The investigators will also perform ...

What is the current status of trial NCT03373604?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2017-12-11. Estimated completion is 2022-05-11.

What interventions are being tested in trial NCT03373604?

The interventions under investigation include: 18F-MK-6240 (DRUG), Lumbar Puncture (optional) (PROCEDURE).

Who is sponsoring clinical trial NCT03373604?

This trial is sponsored by Patrick Lao, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03373604's enrollment target sits among peer trials

71 936th of 2000 higher than 1,064 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03373604, the US trial registry maintained by the National Library of Medicine. NCT03373604 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.